Characterization of human lymphocytes which proliferate "spontaneously" in vitro.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6970131)

Published in Eur J Immunol on November 01, 1980

Authors

A J Treves, V Barak, Z Fuks

Articles by these authors

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (1996) 6.75

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys (2000) 4.99

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys (1998) 3.82

Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med (1977) 3.48

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06

Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell (1995) 3.02

Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med (2000) 2.96

Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 2.71

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys (1996) 2.70

Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med (1997) 2.21

Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell (1998) 2.18

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res (1983) 2.04

Ceramide enables fas to cap and kill. J Biol Chem (2001) 1.88

Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys (1999) 1.81

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst (1992) 1.81

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol (2000) 1.80

Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol (2000) 1.77

The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (1994) 1.73

Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. J Urol (1993) 1.72

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys (2000) 1.71

Expression of basic fibroblast growth factor in normal human tissues. Lab Invest (1990) 1.70

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev (1990) 1.66

Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science (1976) 1.66

Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res (2000) 1.65

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol (1994) 1.62

Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas. Cancer (1973) 1.60

Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest (1976) 1.59

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer J (2001) 1.58

Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci (1991) 1.57

Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. J Clin Oncol (1998) 1.57

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52

Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. Int J Radiat Oncol Biol Phys (2000) 1.50

Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology (1999) 1.49

The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys (1991) 1.46

Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. Radiother Oncol (1995) 1.46

Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J Cell Biochem (1991) 1.45

An equation for the dose response of radiation-induced apoptosis: possible incorporation with the LQ model. Radiother Oncol (1994) 1.43

Clinically relevant optimization of 3-D conformal treatments. Med Phys (1992) 1.42

Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature (1984) 1.42

The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am (2006) 1.42

Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut (1983) 1.42

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys (1997) 1.42

Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J Exp Med (1978) 1.40

The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys (2001) 1.39

The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 1.38

Screening for prostate cancer. Isr J Med Sci (1995) 1.38

Refining the predictive power of the prostate-specific antigen. Int J Radiat Oncol Biol Phys (1993) 1.38

A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys (1988) 1.35

The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys (1993) 1.35

Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer (1975) 1.35

Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res (1989) 1.33

Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information? Cancer (1998) 1.32

The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys (1991) 1.30

Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res (1991) 1.30

Anterior decompression of the spine for metastatic epidural cord compression: a promising avenue of therapy? Ann Neurol (1982) 1.29

The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci U S A (2000) 1.27

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest (1985) 1.27

The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol (1995) 1.26

Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology (1973) 1.26

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer (1999) 1.26

Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26

Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res (1994) 1.26

12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res (1998) 1.25

Total-skin electron treatment of mycosis fungoides. Radiology (1971) 1.25

Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun (1996) 1.24

Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res (1984) 1.23

Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol (1999) 1.23

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol (1999) 1.23

Capacity of thymic cells to effect target cell lysis following treatment with concanavalin A. Cell Immunol (1972) 1.20

Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol (1987) 1.19

Use of total lymphoid irradiation in tissue transplantation in mice. Transplant Proc (1977) 1.18

Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol (1997) 1.17

Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15

Transplantation tolerance after total lymphoid irradiation. Transplant Proc (1979) 1.15

Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase. J Biol Chem (1999) 1.15

Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res (1991) 1.14

Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. J Biol Chem (2000) 1.14

The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J Periodontol (1994) 1.13

Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol (1974) 1.13

Constitutive secretion of interleukin 1 by human monocytes. Eur J Immunol (1983) 1.12

Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol (2001) 1.12

Non-Hodgkin's lymphomas. V. Results of radiotherapy. Cancer (1973) 1.11

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol (1997) 1.11

Ceramide: a signal for apoptosis or mitogenesis? J Exp Med (1995) 1.11

Ceramide signaling in apoptosis. Br Med Bull (1997) 1.10

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br J Cancer (1984) 1.10

Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol (1994) 1.10

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. Int J Radiat Oncol Biol Phys (2001) 1.09

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol (1999) 1.09

The isolation and purification of human peripheral blood monocytes in cell suspension. J Immunol Methods (1980) 1.08

Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int J Cancer (1985) 1.08

Tumor cell attachment to the vascular endothelium and subsequent degradation of the subendothelial extracellular matrix. Exp Cell Res (1982) 1.08